An estimated 20–30% of ADEs requiring hospitalization have a prominent genetic component, and the frequency of some ADEs (e.g., ACE inhibitor induced angioedema, G6PD related hemolysis) is well-known to vary by ancestry30,31. This evidence concerns the gene ACE and angioedema.